Global Lithium Therapy Market Research Report 2022

Lithium is a chemical element found in nature that is sometimes used in medicines to treat certain mental illnesses, such as bipolar disorder. Lithium can treat acute mania and help with longer-term mood stabilisation.It's also used in treating some types of depression and other types of mental illness.
Due to the COVID-19 pandemic, the global Lithium Therapy market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Lithium Therapy market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Lithium Therapy landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Capsule accounting for % of the Lithium Therapy global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Online Sales segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
The global major manufacturers of Lithium Therapy include Bristol-Myers Squibb, Intellipharmaceutics, Pfizer, Eli Lilly, Astrazeneca, GlaxoSmithKline, Lundbeck, Allergan and Otsuka Pharmaceutical, etc. In terms of revenue, the global 3 largest players have a % market share of Lithium Therapy in 2021.
This report focuses on Lithium Therapy volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Lithium Therapy market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global Lithium Therapy Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Capsule
Solution
Tablet
Others
Segment by Application
Online Sales
Offline Sales
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Bristol-Myers Squibb
Intellipharmaceutics
Pfizer
Eli Lilly
Astrazeneca
GlaxoSmithKline
Lundbeck
Allergan
Otsuka Pharmaceutical
Takeda
NHU Group
Shionogi
APOTEX
Kanghong Pharma
HUAHAI